arrow
N

Naomi Hasegawa

national center for neurology & psychiatry - japan
H指数:15
被引数:621

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Educational Spillover Effect within a Cluster: Impact of Guideline Education for Schizophrenia and Major Depressive Disorder on Psychiatrists’ Treatment Behavior in a Real-World Multicenter Study

集群内的教育溢出效应:在真实世界多中心研究中,关于精神分裂症和重度抑郁症的指南教育对精神科医生治疗行为的影响

2026-02-230
PRE
Long-Term Impact of EGUIDE Training on Facility-Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study

EGUIDE培训对精神分裂症和重度抑郁症全院指南依从率的长期影响:一项多中心研究

2025-12-010
OAAI
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting

电休克治疗后住院重度抑郁症患者的维持期药物治疗:一项真实世界临床环境中的198例处方研究

2025-10-110
OAAI
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study

氯氮平的可及性与精神分裂症患者治疗难治性亚组诊断、抗精神病药单药治疗以及合并使用精神活性药物之间的关联:一项真实世界全国性研究

2025-03-280
OA
EFFECT OF EDUCATION REGARDING TREATMENT GUIDELINES FOR SCHIZOPHRENIA AND DEPRESSION ON THE TREATMENT BEHAVIOR OF PSYCHIATRISTS: A MULTICENTER STUDY

关于精神分裂症和抑郁症治疗指南的教育对精神科医生治疗行为的影响:一项多中心研究

2025-02-120
OA
ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITANT PSYCHOTROPICS IN OVERALL SCHIZOPHRENIA TREATMENT: A REAL-WORLD NATIONWIDE STUDY

氯氮平可用机构的关联性,以及是否为治疗难治性精神分裂症亚组诊断,与抗精神病药单一疗法较高率和总体精神分裂症治疗中其他合并精神药物较低率的关联:一项真实世界全国性研究

2025-02-120
OA
CHANGE OF PRESCRIPTION FOR PATIENTS WITH SCHIZOPHRENIA DURING ADMISSION: REAL-WORLD PRESCRIBING SURVEYS FROM THE EFFECTIVENESS OF GUIDELINES FOR DISSEMINATION AND EDUCATION PSYCHIATRIC TREATMENT PROJECT

精神分裂症患者入院期间的处方变更:来自《指南传播与教育精神科治疗项目》的真实世界处方调查

2025-02-120
OA
PROPOSAL FOR NOVEL PATIENT CLASSIFICATION WITH ENLARGED LATERAL VENTRICLES AND COGNITIVE DECLINE BASED ON DATA-DRIVEN ANALYSIS OF NEUROIMAGING IN PSYCHIATRIC DISORDERS AND CLINICAL CHARACTERIZATION

基于精神科疾病神经影像数据驱动分析及临床特征,提出针对伴有侧脑室扩大和认知衰退的新型患者分类方案

2025-02-120
OA
Tablet-Based Cognitive and Eye Movement Measures as Accessible Tools for Schizophrenia Assessment: Multisite Usability Study
2024-05-300
OA
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
2024-05-290
OAAI
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
2023-09-086
OA
Cerebral cortical structural alteration patterns across four major psychiatric disorders in 5549 individuals
2023-08-1812
OAAI
Subcortical volumetric alterations in four major psychiatric disorders: a mega-analysis study of 5604 subjects and a volumetric data-driven approach for classification
2023-08-049
OAAI
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project
2023-06-283
OAAI
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project
2022-12-263
OAAI
Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis
2022-11-093
PRE
Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study
2022-08-016
OAAI